Showing results (871-880 of 1,008) with videos related to
Sort By:
Pageof 101
Cardiovascular Therapeutics|November 28, 2013
The effects of aging on apoptosis following myocardial infarctionAndrew J Boyle, Joy Hwang, Jianqin Ye, et al.Cardiovascular Therapeutics|November 28, 2013
Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathyJosef Finsterer, Claudia Stöllberger, Gernot Paul, et al.Cardiovascular Therapeutics|October 22, 2013
Antiarrhythmic drug therapy for maintaining sinus rhythm early after pulmonary vein ablation in patients with symptomatic atrial fibrillationChristian Sohns, Valerie von Gruben, Samuel Sossalla, et al.Cardiovascular Therapeutics|January 1, 2010
Benefits and risks of maintaining normothermia during cardiopulmonary bypass in adult cardiac surgery: a systematic reviewKwok M Ho, Jen Aik TanCardiovascular Therapeutics|January 16, 2010
Dronedarone: current evidence and future questionsJeremy A Schafer, Nicole K Kjesbo, Patrick P GleasonCardiovascular Therapeutics|June 5, 2018
Predictors and consequences of postdischarge gastrointestinal bleeding after percutaneous coronary interventionPei Zhu, Xiaofang Tang, Jingjing Xu, et al.Cardiovascular Therapeutics|November 20, 2017
Tetrahydrobiopterin (BH4 ): Targeting endothelial nitric oxide synthase as a potential therapy for pulmonary hypertensionBahaa N Francis, Maram Salameh, Rola Khamisy-Farah, et al.Cardiovascular Therapeutics|June 13, 2022
L-Carnitine Alleviates the Myocardial Infarction and Left Ventricular Remodeling through Bax/Bcl-2 Signal PathwayHao-Ran Li, Xiao-Ming Zheng, Yan Liu, et al.Cardiovascular Therapeutics|June 10, 2014
Outcome of patients with severe PH due to lung disease with and without targeted therapyTobias J Lange, Miriam Baron, Isabella Seiler, et al.Cardiovascular Therapeutics|April 17, 2015
Bivalirudin in percutaneous coronary intervention, is it the anticoagulant of choice?Ahmed Mahmoud, Marwan Saad, Akram Y Elgendy, et al.Pageof 101